These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


231 related items for PubMed ID: 1520294

  • 1. Selective and potent inhibition of different hepatic UDP-glucuronosyltransferase activities by omega,omega,omega-triphenylalcohols and UDP derivatives.
    Said M, Noort D, Magdalou J, Ziegler JC, van der Marel GA, van Boom JH, Mulder GJ, Siest G.
    Biochem Biophys Res Commun; 1992 Aug 31; 187(1):140-5. PubMed ID: 1520294
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of UDP-glucuronosyltransferase activity by possible transition-state analogues in rat-liver microsomes.
    Noort D, Coughtrie MW, Burchell B, van der Marel GA, van Boom JH, van der Gen A, Mulder GJ.
    Eur J Biochem; 1990 Mar 10; 188(2):309-12. PubMed ID: 2108023
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of UDP-glucuronosyltransferase by 5'-O-amino acid and oligopeptide derivatives of uridine: structure-activity relationships.
    Naydenova ZG, Grancharov KC, Alargov DK, Golovinsky EV, Stanoeva IM, Shalamanova LD, Pajeva IK.
    Z Naturforsch C J Biosci; 1998 Mar 10; 53(3-4):173-81. PubMed ID: 9687161
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
    Pritchard M, Fournel-Gigleux S, Siest G, Mackenzie P, Magdalou J.
    Mol Pharmacol; 1994 Jan 10; 45(1):42-50. PubMed ID: 8302279
    [Abstract] [Full Text] [Related]

  • 8. Selective inhibition of glucuronidation by 2,2,2-triphenylethyl-UDP in isolated rat hepatocytes: conjugation of harmol, 3,3',5-triiodothyronine, and N-hydroxy-2-acetylaminofluorene.
    Noort D, Meijer EA, Visser TJ, Meerman JH, Van der Marel GA, Van Boom JH, Mulder GJ.
    Mol Pharmacol; 1991 Aug 10; 40(2):316-20. PubMed ID: 1908549
    [Abstract] [Full Text] [Related]

  • 9. Glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes: enzyme inhibition by drugs and steroid hormones.
    Herber R, Magdalou J, Haumont M, Bidault R, van Es H, Siest G.
    Biochim Biophys Acta; 1992 Jun 09; 1139(1-2):20-4. PubMed ID: 1610916
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibitory effects of uridine diphosphate on UDP-glucuronosyltransferase.
    Yokota H, Ando F, Iwano H, Yuasa A.
    Life Sci; 1998 Jun 09; 63(19):1693-9. PubMed ID: 9806225
    [Abstract] [Full Text] [Related]

  • 12. Glucuronidation of haloperidol by rat liver microsomes: involvement of family 2 UDP-glucuronosyltransferases.
    Narayanan R, LeDuc B, Williams DA.
    Life Sci; 2004 Apr 02; 74(20):2527-39. PubMed ID: 15010263
    [Abstract] [Full Text] [Related]

  • 13. Kinetic and inhibitor studies of 4-methylumbelliferone and 1-naphthol glucuronidation in human liver microsomes.
    Miners JO, Lillywhite KJ, Matthews AP, Jones ME, Birkett DJ.
    Biochem Pharmacol; 1988 Feb 15; 37(4):665-71. PubMed ID: 3124857
    [Abstract] [Full Text] [Related]

  • 14. Kinetic properties of the rat intestinal microsomal 1-naphthol:UDP-glucuronosyl transferase. Inhibition by UDP and UDP-N-acetylglucosamine.
    Koster AS, Noordhoek J.
    Biochim Biophys Acta; 1983 Nov 22; 761(1):76-85. PubMed ID: 6416300
    [Abstract] [Full Text] [Related]

  • 15. Characterization of a new class of inhibitors of the recombinant human liver UDP-glucuronosyltransferase, UGT1*6.
    Battaglia E, Elass A, Drake RR, Paul P, Treat S, Magdalou J, Fournel-Gigleux S, Siest G, Vergoten G, Lester R.
    Biochim Biophys Acta; 1995 Jan 18; 1243(1):9-14. PubMed ID: 7827113
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effects of adenine nucleotides and related substances on UDP-glucuronosyltransferase: structure-effect relationships and evidence for an allosteric mechanism.
    Nishimura Y, Maeda S, Ikushiro S, Mackenzie PI, Ishii Y, Yamada H.
    Biochim Biophys Acta; 2007 Nov 18; 1770(11):1557-66. PubMed ID: 17764847
    [Abstract] [Full Text] [Related]

  • 17. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1.
    Watanabe Y, Nakajima M, Ohashi N, Kume T, Yokoi T.
    Drug Metab Dispos; 2003 May 18; 31(5):589-95. PubMed ID: 12695347
    [Abstract] [Full Text] [Related]

  • 18. Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes.
    Williams JA, Ring BJ, Cantrell VE, Campanale K, Jones DR, Hall SD, Wrighton SA.
    Drug Metab Dispos; 2002 Nov 18; 30(11):1266-73. PubMed ID: 12386134
    [Abstract] [Full Text] [Related]

  • 19. UDP-glucuronyltransferase in perfused rat liver and in microsomes - III. Effects of galactosamine and carbon tetrachloride on the glucuronidation of 1-naphthol and bilirubin.
    Otani G, Abou-El-Makarem MM, Bock KW.
    Biochem Pharmacol; 1976 Jun 01; 25(11):1293-7. PubMed ID: 820350
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of UDP-glucuronosyltransferases in rat liver microsomes by natural mutagens and carcinogens.
    Grancharov K, Engelberg H, Naydenova Z, Müller G, Rettenmeier AW, Golovinsky E.
    Arch Toxicol; 2001 Dec 01; 75(10):609-12. PubMed ID: 11808922
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.